NASDAQ
Lexicon Pharmaceuticals, Inc. (LXRX) has a free cash flow growth of 14.52% as of Friday, May 29, 2026. This represents a 133.57% increase compared to its 12-month average of -43.26%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.